Vaccines

08 Sep 2011 NOVAVAX Announces Publication of Results from H5N1 Influenza Virus-Like Particle Vaccine Phase I/IIa Clinical Trial
07 Sep 2011 ImmunoCellular Therapeutics gives Site Update for Phase II trial of ICT-107
01 Sep 2011 Pevion grants CSL option right to its therapeutic Candida vaccine
31 Aug 2011 Sirona Biochem Develops Cancer Vaccine Antigen
31 Aug 2011 Selecta Biosciences Awarded Subcontract to Develop a Synthetic Nanoparticle Vaccine for Malaria
29 Aug 2011 Positive avian flu trial data using Isconova’s Matrix M published
26 Aug 2011 Results of Emergent BioSolutions Phase 1a Study on Adjuvanted BioThrax Anthrax Vaccine Published in the Journal Vaccine
25 Aug 2011 Bionor Pharma ASA Announces Exploratory Study of Its Lead Therapeutic HIV-Vaccine Candidate Vacc-4x in Combination With Leading Cancer Drug
24 Aug 2011 NanoBio’s Intranasal RSV Vaccine Induces Robust Immunity in Animals
22 Aug 2011 Mayo Clinic Receives FDA Approval for Ovarian and Breast Cancer Vaccines
22 Aug 2011 Isconova and Genocea expand collaboration
22 Aug 2011 Immune Response BioPharma Reports NeuroVax MS Vaccine Increased Results with Women Taking Estrogen
18 Aug 2011 Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
15 Aug 2011 Inviragen and University of Texas Medical Branch Receive Funding for Development of a Novel Recombinant Chikungunya Virus Vaccine
12 Aug 2011 Advaxis Completes Pre-IND Meeting for ADXS-PSA
12 Aug 2011 TapImmune to Sponsor Phase 1 Breast Cancer Vaccine Trial Following Recent FDA Approval of Investigational New Drug Application
12 Aug 2011 New Tuberculosis Vaccine Enters Phase IIb Proof-of-Concept Trial in People Living with HIV in Senegal and South Africa
10 Aug 2011 Genesis Biopharma Signs Cooperative Research and Development Agreement With the National Cancer Institute to Develop Cancer Immunotherapies
05 Aug 2011 New Hope for Immune Therapy for Children and Young Adults With Type 1 Diabetes: Founder of Orban Biotech's Landmark Findings for Abatacept Published in The Lancet
03 Aug 2011 International Vaccine Institute and Inviragen Announce a Collaboration to Accelerate Development of a Dengue Vaccine
03 Aug 2011 NanoBio Secures Novel Antigen Source for its Intranasal RSV Vaccine
03 Aug 2011 Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine (PCV)
01 Aug 2011 AbD Serotec and Merck Sign License Agreement for Use of HuCAL GOLD in Vaccine Research
26 Jul 2011 VaxOnco to Sponsor Phase I Trial of a Folate Receptor Alpha-targeted Breast/Ovarian Cancer Therapeutic Vaccine That Recently Received Investigational New Drug Approval From FDA
21 Jul 2011 Vical Reports Successful Nonclinical Results With Vaxfectin(R) Adjuvant

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top